These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 2123104

  • 21. Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(-)-deprenyl and clorgyline.
    Sharma U, Roberts ES, Hollenberg PF.
    Drug Metab Dispos; 1996 Jun; 24(6):669-75. PubMed ID: 8781784
    [Abstract] [Full Text] [Related]

  • 22. [Current status of type A and type B monoamine oxidase (author's transl)].
    Suzuki O.
    Seikagaku; 1980 Jun; 52(3):158-62. PubMed ID: 6774035
    [No Abstract] [Full Text] [Related]

  • 23. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG, Baker GB.
    J Affect Disord; 1995 Dec 13; 35(3):125-9. PubMed ID: 8749840
    [Abstract] [Full Text] [Related]

  • 24. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S, Nahrstedt H, Panten U.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov 13; 324(3):190-5. PubMed ID: 6419132
    [Abstract] [Full Text] [Related]

  • 25. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
    Holt A, Todd KG, Baker GB.
    Ann N Y Acad Sci; 2003 Dec 13; 1009():309-22. PubMed ID: 15028605
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.
    Boden R, Botting R, Coulson P, Spanswick G.
    Br J Pharmacol; 1984 May 13; 82(1):151-4. PubMed ID: 6428496
    [Abstract] [Full Text] [Related]

  • 29. MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B.
    Zreika M, McDonald IA, Bey P, Palfreyman MG.
    J Neurochem; 1984 Aug 13; 43(2):448-54. PubMed ID: 6736960
    [Abstract] [Full Text] [Related]

  • 30. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H, Castagnoli K, Van Der Schyf C, Mabic S, Igarashi K, Castagnoli N.
    J Pharmacol Exp Ther; 1999 Nov 13; 291(2):856-64. PubMed ID: 10525109
    [Abstract] [Full Text] [Related]

  • 31. Monoamine oxidase substrates and substrate affinity.
    Domino EF.
    Schizophr Bull; 1980 Nov 13; 6(2):292-7. PubMed ID: 6769148
    [Abstract] [Full Text] [Related]

  • 32. Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity.
    Seymour CB, Mothersill C, Mooney R, Moriarty M, Tipton KF.
    Br J Cancer; 2003 Nov 17; 89(10):1979-86. PubMed ID: 14612913
    [Abstract] [Full Text] [Related]

  • 33. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
    Glover V, Pycock CJ, Sandler M.
    Br J Pharmacol; 1983 Sep 17; 80(1):141-8. PubMed ID: 6418254
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Determination of the absolute concentrations of monoamine oxidase A and B in human tissues.
    O'Carroll AM, Anderson MC, Tobbia I, Phillips JP, Tipton KF.
    Biochem Pharmacol; 1989 Mar 15; 38(6):901-5. PubMed ID: 2495009
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The depletion of rat cortical norepinephrine and the inhibition of [3H]norepinephrine uptake by xylamine does not require monoamine oxidase activity.
    Dudley MW.
    Life Sci; 1988 Mar 15; 43(23):1871-7. PubMed ID: 3143879
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions.
    Maragos WF, Tillman PA, Chesnut MD, Jakel RJ.
    Brain Res; 1999 Jul 10; 834(1-2):168-72. PubMed ID: 10407109
    [Abstract] [Full Text] [Related]

  • 40. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
    Kan JP, Steinberg R, Mouget-Goniot C, Worms P, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan 10; 240(1):251-8. PubMed ID: 3100771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.